Friday 6 November 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue: +0.56%
EPS: +357.1%
Free cash flow: +66.0%
Total debt: +2.66%

Quarter to July 2026, against a year earlier

63.44 0.98 −1.52%

Follow COO

Alert me

Market cap: $12.1B
P/E: 21.7×
Fwd P/E: 17.5×
Dividend yield: —
F-score: 5/9
Altman Z: 3.48
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

The Cooper Companies, Inc. (COO) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, The Cooper Companies, Inc. (COO) trades at a price to free cash flow of 18.1×. Over the past ten years it has ranged from 15.2× (September 2026) to 159× (May 2024); the current reading is higher than 1% of that period. That is below the Medical Instruments & Supplies industry median of 23.5× and below the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/COO/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="The Cooper Companies, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/COO/metrics/price-to-free-cash-flow">The Cooper Companies, Inc. (COO) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	32.1×	(55.59%)
FY2024	72.3×	0.74%
FY2023	71.7×	139.49%
FY2022	30.0×	(24.36%)
FY2021	39.6×	(55.66%)
FY2020	89.3×	161.64%
FY2019	34.1×	27.93%
FY2018	26.7×	5.93%
FY2017	25.2×	5.34%
FY2016	23.9×	(52.87%)

Period	Price to free cash flow	Change
Jul 2026	20.6×	(4.41%)
Apr 2026	21.5×	(33.01%)
Jan 2026	32.1×	0.17%
Oct 2025	32.1×	(6.17%)
43 more quarters	Free account

Against its own ten years

Low 15.2× High 159×

Ten-year median 37.2×

Current reading's percentile 1

Company	Price to free cash flow
SOLV Solventum Corporation compare	n/m
BAX Baxter International Inc. compare	11.6×
ALGN Align Technology, Inc. compare	16.8×
COO The Cooper Companies, Inc.	18.1×
AVTR Avantor, Inc. compare	23.3×
ATR AptarGroup, Inc. compare	31.0×
BLCO Bausch + Lomb Corporation compare	31.4×
TFX Teleflex Incorporated compare	125×
RGEN Repligen Corporation compare	170×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

The Cooper Companies, Inc. (COO) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on COO

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on COO

Stockrow Weekly